Using quantitative reverse transcription‐polymerase chain reaction (QRT‐PCR), Qu et al have recorded dramatically higher levels of PTHR1 expression in a 40‐patient sampling of osteosarcomas (vs normal control tissues), culminating in adverse clinical outcome.29 The gene discussed is PTH1R; the disease is osteosarcoma.